These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22763933)

  • 1. [Amyotrophic lateral sclerosis--diagnosis and treatment].
    Jung HH; Neumann M; Bloch KE
    Praxis (Bern 1994); 2012 Jul; 101(14):907-14. PubMed ID: 22763933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
    Fang T; Al Khleifat A; Meurgey JH; Jones A; Leigh PN; Bensimon G; Al-Chalabi A
    Lancet Neurol; 2018 May; 17(5):416-422. PubMed ID: 29525492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis.
    Gordon PH; Mitsumoto H; Hays AP
    Sci Aging Knowledge Environ; 2003 Sep; 2003(35):dn2. PubMed ID: 12954882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Kovalchuk MO; Heuberger JAAC; Sleutjes BTHM; Ziagkos D; van den Berg LH; Ferguson TA; Franssen H; Groeneveld GJ
    Clin Pharmacol Ther; 2018 Dec; 104(6):1136-1145. PubMed ID: 29672831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinicopathological study of familial amyotrophic lateral sclerosis with special reference to the mode of motoneuron loss in the spinal ventral horn].
    Terao S; Sobue G; Mukai E; Murakami N; Hashizume Y
    Rinsho Shinkeigaku; 1991 Sep; 31(9):960-9. PubMed ID: 1769159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
    Yoo YE; Ko CP
    Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
    Cifra A; Nani F; Nistri A
    Eur J Neurosci; 2011 Mar; 33(5):899-913. PubMed ID: 21324003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrodiagnostic criteria for early diagnosis of bulbar-onset ALS: a comparison of El Escorial, revised El Escorial and Awaji algorithm].
    Bresch S; Delmont E; Soriani MH; Desnuelle C
    Rev Neurol (Paris); 2014 Feb; 170(2):134-9. PubMed ID: 24239347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against.
    Ludolph AC; Riepe MW
    Neurology; 1999; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enlargement of the Nissl substance as a manifestation of early damage to spinal cord motoneurons in amyotrophic lateral sclerosis.
    Dziewulska D; Gogol A; Gogol P; Rafalowska J
    Clin Neuropathol; 2013; 32(6):480-5. PubMed ID: 23743157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis.
    Camu W; Tremblier B; Plassot C; Alphandery S; Salsac C; Pageot N; Juntas-Morales R; Scamps F; Daures JP; Raoul C
    Neurobiol Aging; 2014 May; 35(5):1198-205. PubMed ID: 24378089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior cysts of the spine: a difficult differential diagnosis to amyotrophic lateral sclerosis.
    Schmalbach S; Petri S; Götz F; Dengler R; Krampfl K
    J Neurol; 2008 Nov; 255(11):1662-9. PubMed ID: 18677632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glutamate antagonist].
    Shindo M
    No To Shinkei; 1998 Jul; 50(7):597-605. PubMed ID: 9739517
    [No Abstract]   [Full Text] [Related]  

  • 20. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria?
    Okita T; Nodera H; Shibuta Y; Nodera A; Asanuma K; Shimatani Y; Sato K; Izumi Y; Kaji R
    J Neurol Sci; 2011 Mar; 302(1-2):29-32. PubMed ID: 21215419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.